Empowering New Zealand Nurses for Excellence in Healthcare
Bicultural Structure
Membership includes belonging to a bicultural organisation focused on professional nursing issues and community health.
Insurance Coverage
Members receive up to $1 million indemnity insurance in New Zealand (not applicable for retired members). (Conditions apply).
Access to Publications
Members have access to the ‘Nursing Praxis in Aotearoa New Zealand’ journal.
Influence and Networking
Members contribute to a significant influencer in health policy decision-making and join a dynamic network of professional nurses committed to high standards of practice.
10 March 2026
Decision to widen access to existing medicines and fund a new medicine for the treatment of cystic fibrosis
Pharmac has made a decision to widen access to Trikafta and Kalydeco, and to fund Alyftrek for the treatment of cystic fibrosis.From 1 April 2026, the following changes will be implemented for people with eligible mutations: Widened access to Trikafta (elexacaftor/tezacaftor/ivacaftor) Widened access to Kalydeco (ivacaftor) Funding of a new medicine, Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) This decision follows consultation with people with cystic fibrosis, their families, healthcare...
10 March 2026
Continuing Professional DevelopmentPodcasts | Webinars | Gems | eLearning | MedCases
Dear Andrea, NEXT WEEK! Goodfellow Symposium 2026 And while we wait, here are our latest webinars and podcasts: Functional gastrointestinal conundrums: Utilising the MDT WEBINAR 17 March: The team from Allevia Hospitals will distil key practical tips and demonstrate how a team-based, multidisciplinary approach can help clinicians manage common GI conundrums more effectively. Register here Adult ADHD in practice: A clinical Q&A WEBINAR 19 March: Join David Codyre for an entire...
10 March 2026
Supply Issue: Ticagrelor tab 90 mg (Sandoz)
Kia ora Supply Issue: We are writing to inform you that due to shipping delays, Sandoz expects to run out of ticagrelor 90mg tab by mid-March 2026. Key Dates: It is estimated that ticagrelor 90mg tab (Sandoz) stock will be depleted by mid-March An alternative brand Ticagrelor Mylan 90mg tab was listed from 1 March 2026 Key messages: Ticagrelor Mylan is from the Italian market. The box will be over labelled with English text, and the blister packs have Italian text. Ticagrelor Mylan...
9 March 2026
Pharmac Update: Primary Care Prescribers | 06 March 2026
Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 06 March 2026. It includes information on: New updates Resolved Supply Issues Changes to antiretroviral dispensing – effective 1 March 2026 From 1 March 2026, all listed antiretroviral (Community Schedule) treatments changed to 90‑day dispensing and may be prescribed and dispensed accordingly where appropriate. Supply issue: ticagrelor tab 90 mg (Sandoz) Due to...
9 March 2026
Conflict in the Middle East: Impact on the supply chain
Pharmac has asked suppliers to notify us early of any supply risks, so we can act sooner and support ongoing access to medicines and medical devices. Read more Have your say We’re consulting on upcoming changes to how the Pharmaceutical Schedule will work. Changes to how the Pharmaceutical Schedule will work (consultation closes 13 March 2026) New medicine supply notices Proctosedyl (suppositories) Unfortunately, AFT (the supplier) has run out of Proctosedyl suppositories (Pharmacode:...
5 March 2026
Proposal to fund letermovir to prevent serious infection
Pharmac is seeking feedback on a proposal to fund letermovir, a medicine that helps prevent serious viral infection in people with very weak immune systems. Under this proposal, letermovir would be funded from 1 May 2026 for people who have had a stem cell transplant, as well as a small number of other people with severe immunosuppression who cannot use other funded antiviral medicines. We have heard from clinicians involved in stem cell transplant care and from Pharmac’s clinical advisors...
4 March 2026
Ministry of Health - Health Improvement & Innovation Digest
Issue 337 - 5 March 2026 Welcome to the fortnightly Health Improvement and Innovation Digest. The Digest has links to key evidence of interest, with access to new content arranged by topic. You can forward this newsletter to others who may be interested in receiving it. They can register and subscribe here . You can also access other recent issues of the digest here. If you have any queries, please email us at library@health.govt.nz . Article Access For articles that aren't open access,...
3 March 2026
Topical permethrin better than oral ivermectin
A randomized trial compared oral ivermectin with 5% permethrin for treating scabies in index cases and household clusters of up to eight people 1 . Ivermectin 200 µg/kg was taken with food on days 0 and 10, while permethrin was applied head-to-toe, including hair, genitalia, and children’s faces, left on overnight, and washed off after at least eight hours. Emollients and textile decontamination were advised. Children under 15 kg received permethrin only. Cluster-level cure rates were...
3 March 2026
Reminder: Initial consultation on Ngā paerewa Health and disability services standard 2021 closes in two weeks
Kia ora koutou, This is a quick reminder that our initial consultation questionnaire regarding the review of Ngā paerewa Health and disability services standard 2021 (Ngā Paerewa) will close in two weeks on 16 March 2026 . If you have already submitted your feedback, thank you for your time and please disregard this email. We acknowledge that this is a relatively short consultation window. We want to reassure you that this is an initial questionnaire only. Its purpose is to help the...
2 March 2026
Pharmac Update: Primary Care Prescribers | 27 February 2026
Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 27 February 2026. It includes information on: New updates Resolved Supply Issues Changes to Antiretroviral Dispensing – Effective 1 March 2026 From 1 March 2026, all listed antiretroviral (community schedule) treatments will default to 90‑day dispensing and may be prescribed and dispensed accordingly where appropriate. Improving access to treatments in the...
2 March 2026
Reminder of discontinuation: clomipramine 10mg Teva
We are writing to remind you that clomipramine capsules 10mg will be delisted (no longer funded.) Key Points: The delist date from the Pharmaceutical Schedule is 1 April 2026 Clomipramine 25mg tablets will remain available and listed on the Pharmaceutical Schedule Please continue to consider alternative options for patients that require the lower 10mg dose Please share this information with your colleagues and within your networks. If you have any queries, please contact us at...
2 March 2026
Have your say
We’re consulting on upcoming changes to how the Pharmaceutical Schedule will work. Changes to how the Pharmaceutical Schedule will work (consultation closes 13 March 2026) New medicine supply notices Pedialyte: Claiming update Urgent action required: Pharmacies need to check any claims they made for Pedialyte in February 2026. See the website for more details. Ticagrelor (Tab 90 mg) (Pharmacode: 2638770) The supplier anticipates running out in mid-March. A S29 alternative has been listed...
26 February 2026
Nurse Practitioner
Nurse Practitioner Permanent full-time 0.9-1.0 FTE | Salary $142,470-$157,252 depending on experience The Gardens, Manurewa location, with free parking on site Onsite café with discounted coffee, health insurance, boutique 2 nd edition store and more… At Tōtara Hospice, you’re not just a nurse — you’re a purpose-driven clinician making a real impact every day. Imagine starting your morning surrounded by native trees, peaceful gardens, and a calm oasis far from the city rush — maybe with a...
26 February 2026
NP contract roles (0.2 – 0.8FTE) - Greater Wellington Region
We’re seeking NPs for contract roles across the Wellington region to provide weekly rounds to Aged Residential Care (ARC) facilities, delivering high-quality care to older patients with complex needs. You will work closely with onsite nurses and care teams to: Provide excellent clinical care to ARC residents (rest home level care and above). Complete regular scheduled visits onsite, with key tasks including new admission assessments, acute care, regular examinations, and medication reviews...
Areas of interest
